|
PCSA Processa Pharmaceuticals Inc 1533743 |
| Income Statement |
|
Net Income
|
form10-q
|
-3,384,703 |
| Balance Sheet |
|
Current Assets
|
4,838,139 |
|
Assets
|
4,942,152 |
|
Current Liabilities
|
1,219,199 |
|
Liabilities
|
1,221,367 |
|
Equity
|
3,720,785 |
|
Shares Out
|
3,257,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-8,997,321 |
|
Investing Cash Flow
|
-3,244 |
| Market Analysis |
Market Cap
|
4,624,854 |
|
Price
|
0.44 |
|
BVPS
|
1.14 |
|
PB
|
0.39 |
|
EPS
|
-5.36 |
|
PS
|
0.01 |
|
FCF
|
-9,000,565 |
|
| Earnings |
|
| Oct |
Nov |
Dec |
| 10/30 |
-1.03 |
11/13 |
|
|
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view PCSA documents filed with the SEC.
PCSA Filings
Clear
